Please ensure Javascript is enabled for purposes of website accessibility

Albemarle Resets Investor Expectations Lower Through 2020

By Maxx Chatsko - Oct 27, 2019 at 2:45PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The lithium producer reduced full-year 2019 guidance and expects pricing pressure to remain in 2020, but better days are ahead.

At the beginning of 2016, lithium stocks were considered de facto growth investments. The argument was simple: The world produced relatively little lithium compared with what would be needed to keep pace with a tidal wave of electric vehicle (EV) launches at the beginning of the next decade. 

At the end of 2019, investors are a little less optimistic about the near-term growth prospects for lithium producers. Case in point: Shares of Albemarle (ALB 2.47%) have now gained just 15% since the beginning of 2016, despite more than doubling from that starting point not too long ago.

The company's preliminary third-quarter 2019 operating results, in which Albemarle walked back full-year 2019 guidance and had some bad news about 2020, demonstrate that headwinds remain. Here's what investors need to know.

A hand drawing a yellow arrow in chalk that is opposing the direction of many other white arrows.

Image source: Getty Images.

These 4 factors impacted the lithium business

Albemarle doesn't report official and finalized Q3 2019 operating results until Nov. 7, but decided to set expectations for investors in light of several disappointing developments. Here are the quarterly numbers the business expects to report and how they compare with the actual results from the year-ago period:  


Preliminary Q3 2019 Outlook

Actual Q3 2018


Adjusted earnings per share 




Net income

$155 million

$129.7 million


Adjusted EBITDA

$254 million

$235 million


Lithium segment revenue

$330 million

$271 million


Lithium segment adjusted EBITDA

$128 million

$114 million


Data source: Albermarle. 

As the year-over-year comparison shows, the business is by no means struggling. It's just that both Albemarle and Wall Street expected even more. For instance, while the company expects to grow adjusted EPS handsomely from the year-ago period, the average Wall Street estimate for Q3 2019 adjusted EPS is $1.62, according to 21 estimates compiled by Yahoo! Finance. 

Investors with a long-term mind-set might not see much to worry about for the lithium stock. That argument is bolstered considering that the primary factors affecting lithium operations in Q3 2019 were mostly outside of the company's control. 

  • Weather: Typhoon Tapah kept Chinese ships locked in harbors at the end of September, which delayed lithium shipments out of Shanghai from September to October. That pushed roughly $15 million in EBITDA to the fourth quarter of 2019. 
  • Pricing pressure: Average selling prices are expected to have been flat to slightly up in Q3 compared with the year-ago period, but China's slowing economy continued to drag on the business. Albemarle said pricing pressure in China wiped away roughly $5 million in quarterly EBITDA.
  • Production issues: Operations in La Negra, Chile, encountered setbacks while ramping up production volumes, which isn't unusual for large-scale engineering projects. Albemarle has since fixed the issues and the asset is operating at full capacity. But the delay forced the company to purchase (more expensive) lithium from other producers to meet supply commitments. That reduced EBITDA by $10 million -- and the company said it will rely on third-party production in Q4, too.
  • An accounting error: OK, the company has full responsibility for this one. Albemarle realized it had made an error when tallying the value of lithium inventory in a previous period. It took a $7 million noncash charge in Q3 to make things right.

In all, factors outside of Albemarle's control are expected to reduce Q3 2019 EBITDA by about $30 million, although half of that will be recouped in the fourth quarter. Nonetheless, management decided to reduce full-year 2019 guidance as follows.


Prior Guidance

New Guidance

New Guidance Change from Actual 2018 Results


$3.75 billion

$3.65 billion


Adjusted EBITDA

$1.10 billion

$1.04 billion


Adjusted EPS

$6.25 to $6.65

$6.00 to $6.20


Data source: Albemarle.

The reduced guidance for 2019 still reflects solid growth over the performance from 2018, but management and analysts had expected better. More chilling is the fact that Albemarle told investors full-year 2020 adjusted EBITDA is expected to come in lower than the amount generated in 2019. The reasons are simple: Lithium selling prices remain under pressure and the company isn't bringing any new production capacity on line.

But there is a silver lining to the current volatility in the lithium market. Albemarle significantly reduced its near-term lithium production growth plans several months ago. As a result, it now expects capital expenditures in its multiyear strategy to fall from $5 billion to just $3.5 billion, which will allow the business to generate free cash flow in 2021.

Put another way, Albemarle has to go through some operational adjustments in 2019 and 2020, but it will come out better positioned to invest in growth opportunities that are aligned with customer needs and global lithium demand.

Investors must remain patient

Albemarle has scheduled its third-quarter 2019 earnings conference call for Nov. 7, which is when the official operating results will be discussed. The numbers could change from the preliminary tallies reported above, although large deviations from preliminary results are generally rare. More important, investors will get to listen to management explain the path forward for the business with the latest market factors sprinkled in. While the preliminary results are disappointing relative to prior expectations, the business remains on solid footing for the long haul. 

Maxx Chatsko has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Albemarle Corporation Stock Quote
Albemarle Corporation
$265.70 (2.47%) $6.40

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 08/11/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.